News/Compliance & Enforcement/Private Equity Firm Settles with DOJ in False Claims Act Matter Based on Claims Submitted by Its Health Care Portfolio Company

Expert Opinion·Compliance & Enforcement Brief

Private Equity Firm Settles with DOJ in False Claims Act Matter Based on Claims Submitted by Its Health Care Portfolio Company

Bill OlverOctober 3, 2019 · 1 min read

🔒 Members Only

Compounding pharmacy Diabetic Care Rx, LLC d/b/a Patient Care America, two individual executives, and the pharmacy’s private equity fund owner, Riordan, Lewis & Haden, Inc.

🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.

$750/year

Become a Member

Not ready to join? Take the free Pub K Weekly digest.One email. Free. Top industry articles, the community calendar, and the latest job postings.